Theodoros Foukakis: Clinical Trials

3 trials sponsored by Theodoros Foukakis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Theodoros Foukakis: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes
Garmin smartwatch, REBECCA Mobile application, REBECCA PC plug-in - Breast Neoplasms, Breast Cancer
WithdrawnTheodoros Foukakis2024-03-312026-08-14
HR+/HER2- Advanced Breast Cancer and Endocrine Resistance
Palbociclib, Fulvestrant, Capecitabine - Breast Cancer Metastatic
Phase 2TerminatedTheodoros Foukakis422017-10-242024-03-08
A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel
Bevacizumab, Paclitaxel - Breast Cancer
Phase 2CompletedTheodoros Foukakis332012-11-012019-02-27

Conditions studied

Breast Neoplasms (2)  ·  Polyneuropathies (1)

Interventions

Bevacizumab (1)  ·  Capecitabine (1)  ·  Fulvestrant (1)  ·  Paclitaxel (1)  ·  palbociclib (1)

Countries

Sweden (3)  ·  United Kingdom (1)

Top investigators

Jonas Bergh, Professor (1)

NIH funding

2016 (1)